Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US-Mexico-Canada Trade Agreement Sets 10-Year Floor For Biologics Market Exclusivity

Oct 03 2018

• By Brenda Sandburg

Separated jigsaw puzzle pieces with U.S., Canada and Mexico flags. NAFTA trade agreement members concept. 3D Illustration.

Related Content

Trade Deal Looking Worse For Pharma As More Details Emerge

Oct 09 2015

US-Mexico Trade Agreement Elicits Another Battle Over Biologics Data Exclusivity

Aug 28 2018

Global IP Battle: Drug Pricing, Reimbursement Policies Take Center Stage

May 10 2018

Related Companies

Amgen, Inc.

Eli Lilly and Company

Gilead Sciences, Inc.

Pfizer Inc.

Johnson & Johnson

Additional Topics

United States Canada Mexico Trade Policy Intellectual Property Biologics Biosimilars Legal Issues Policy BioPharmaceutical

More from Legal & IP

More from Generics Bulletin

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window